echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Biochemistry News > Biotechnology News > Qilu Pharmaceutical Group's clozapine tablets passed the consistency evaluation and a total of 96 reviews

    Qilu Pharmaceutical Group's clozapine tablets passed the consistency evaluation and a total of 96 reviews

    • Last Update: 2022-01-11
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Recently, Qilu Pharmaceutical's application for consistency evaluation of clozapine tablets was approved by the National Medical Products Administration


    Clozapine tablets are dibenzodiazepine antipsychotics, which exert a powerful sedative and hypnotic effect by directly inhibiting the ascending activation system of the brainstem network structure, and are clinically used for the treatment of refractory schizophrenia


    In 2018, Qilu Pharmaceutical started the consistency evaluation of clozapine tablets


    In addition, Qilu Pharmaceutical's supplementary application for the consistency evaluation of the new specification of nedaplatin for injection (Lube®) was also approved recently, and it is mainly used clinically for head and neck cancer, small cell lung cancer, non-small cell lung cancer, and esophageal cancer.


    Over the years, Qilu Pharmaceutical has adhered to the original intention and mission of "holding the Chinese medicine bottle tightly in its own hands", actively responded to the national centralized procurement policy, and achieved remarkable results


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.